Market Research Logo

Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review

Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review provides

- you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Anavex Life Sciences Corp (Anavex) is a clinical-stage biopharmaceutical company that focuses on developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, other central nervous system (CNS) diseases, pain and various types of cancer. The company’s target indications include Alzheimer’s disease, Parkinson’s disease, Rett syndrome, epilepsy, neuropathic pain, depression, prostate cancer, pancreatic cancer and malignant melanoma. Its pipeline comprises one drug candidate and several compounds in diverse stages of pre-clinical study.

Anavex Life Sciences Corp Key Recent Developments

May 10,2018 Anavex Life Sciences Reports Fiscal Second Quarter 2018 Financial Results
Mar 05,2018 Anavex Life Sciences Announces Management Changes
Feb 07,2018 Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results
Jan 24,2018 Anavex Life Sciences to Present at the Noble Capital Markets 14th Annual Institutional Investor Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Anavex Life Sciences Corp - Key Facts
Anavex Life Sciences Corp - Key Employees
Anavex Life Sciences Corp - Key Employee Biographies
Anavex Life Sciences Corp - Major Products and Services
Anavex Life Sciences Corp - History
Anavex Life Sciences Corp - Company Statement
Anavex Life Sciences Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Anavex Life Sciences Corp - Business Description
Anavex Life Sciences Corp - Corporate Strategy
Anavex Life Sciences Corp - SWOT Analysis
SWOT Analysis - Overview
Anavex Life Sciences Corp - Strengths
Anavex Life Sciences Corp - Weaknesses
Anavex Life Sciences Corp - Opportunities
Anavex Life Sciences Corp - Threats
Anavex Life Sciences Corp - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Anavex Life Sciences Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 10, 2018: Anavex Life Sciences Reports Fiscal Second Quarter 2018 Financial Results
Feb 07, 2018: Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results
Jan 24, 2018: Anavex Life Sciences to Present at the Noble Capital Markets 14th Annual Institutional Investor Conference
Dec 11, 2017: Anavex Life Sciences Reports Fiscal 2017 Financial Results And Provides Update On Therapeutic Programs
Nov 21, 2017: Anavex Life Sciences Reports Newly Published Data on Alzheimer’s Disease Research Demonstrate the Neuroprotective Features of the Sigma-1 Receptor
Aug 07, 2017: Anavex Reports Fiscal Third Quarter 2017 Financial Results
Jul 20, 2017: Anavex Life Sciences Appoints Distinguished Researcher in Neurology and Epilepsy to Scientific Advisory Board
Jul 20, 2017: Anavex Life Sciences appoints scientific advisory board member
May 10, 2017: Anavex Reports Fiscal Second Quarter 2017 Financial Results
May 01, 2017: Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President of Regulatory Affairs
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Anavex Life Sciences Corp, Key Facts
Anavex Life Sciences Corp, Key Employees
Anavex Life Sciences Corp, Key Employee Biographies
Anavex Life Sciences Corp, Major Products and Services
Anavex Life Sciences Corp, History
Anavex Life Sciences Corp, Subsidiaries
Anavex Life Sciences Corp, Key Competitors
Anavex Life Sciences Corp, Ratios based on current share price
Anavex Life Sciences Corp, Annual Ratios
Anavex Life Sciences Corp, Annual Ratios (Cont...1)
Anavex Life Sciences Corp, Interim Ratios
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Anavex Life Sciences Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Anavex Life Sciences Corp, Performance Chart (2013 - 2017)
Anavex Life Sciences Corp, Ratio Charts
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report